Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (107 total)
-
Creator: Fallah MP, Skrip LA.
Subject: Research
Item Type: Publication
Date Last Updated: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Creator: National Institute of Allergy and Infectious Diseases [National Institutes of Health] NIH (NIAID)
Subject: Research
Item Type: Publication
Date Last Updated: 2019-01-04
Description: The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and… -
Creator: Angie M. Boyce and Brian T. Garibaldi.
Subject: Research
Item Type: Publication
Date Last Updated: 2019-02-19
Description: Host genomic research on high-consequence infectious diseases is a growing area, but the ethical, legal, and social implications of such findings related to potential applications of the research have not yet been identified. -
Creator: Angela Vasa, Syra Madad, LuAnn Larson, Colleen S. Kraft, Sharon Vanairsdale, Jonathan D. Grein, Jennifer Garland, Virginia “Madison” Butterworth, and Christopher J. Kratochvil.
Subject: Research
Item Type: Publication
Date Last Updated: 2019-02-19
Description: The use of investigational therapeutics in the care of patients with Ebola virus disease was documented in the literature following the 2013-2016 outbreak. In order to access these types of therapeutics, facilities must have processes in place to… -
Creator: NETEC SPRN Medical Countermeasures Working Group
Subject: Research
Item Type: Publication
Date Last Updated: 2019-02-19
Description: Emerging and re-emerging infectious diseases pose growing global public health threats. However, research on and development of medical countermeasures (MCMs) for such pathogens is limited by the sporadic and unpredictable nature of outbreaks, lack… -
Creator: National Academies Press
Subject: Research
Item Type: Publication
Date Last Updated: 2017-04-12
Description: Table of Contents Front Matter i-xxvi Summary 1-18 1 Introduction 19-36 2 Conducting Clinical Research During an Epidemic 37-82 3 Assessment of Therapeutic Trials 83-112 4 Assessment of Vaccine Trials 113-154 5… -
Creator: U.S. Food and Drug Administration (FDA)
Subject: Research
Item Type: Guide
Date Last Updated: 2018-08-13
Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here. -
Creator: American Society for Microbiology
Subject: Research
Item Type: Video
Date Last Updated: 2018-01-02
Description: This video explores the National Emerging Infectious Diseases Laboratories (NEIDL) security, a Biological Safety Level (BSL)-4 safety suit, and the facility. -
Creator: National Academies of Sciences, E. and Medicine
Subject: Research
Item Type: Publication
Date Last Updated: 2017-10-31
Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to…